Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis
Journal of Clinical Oncology, 04/25/2012
Weide B et al. – The presence of circulating T cells responding to Melan–A or NY–ESO–1 had strong independent prognostic impact on survival in advanced melanoma. The findings support the therapeutic relevance of Melan–A and NY–ESO–1 as targets for immunotherapy



